XERIS Pharmaceuticals is a startup based in the United States, most recent round Acquired, 2 tracked investors.
XERIS Pharmaceuticals is a startup based in the United States. XERIS Pharmaceuticals has been acquired. Brouky records 2 investors associated with the company.
XERIS Pharmaceuticals is a specialty biopharmaceutical company developing improved injectable therapeutics and proprietary formulation technologies (XeriSol and XeriJect) for subcutaneous and intradermal delivery of peptides, proteins, antibodies and small molecules. Its formulations enable highly concentrated, non‑aqueous, ready‑to‑use products for use with auto‑injectors, pens and pumps, offering reduced injection volumes and room‑temperature stability.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.